Unknown

Dataset Information

Hyperoxia improves exercise capacity in cardiopulmonary disease: a series of randomised controlled trials.


ABSTRACT:

Background

The aim of this study was to investigate the overall and differential effect of breathing hyperoxia (inspiratory oxygen fraction (F IO2 ) 0.5) versus placebo (ambient air, F IO2 0.21) to enhance exercise performance in healthy people, patients with pulmonary vascular disease (PVD) with precapillary pulmonary hypertension (PH), COPD, PH due to heart failure with preserved ejection fraction (HFpEF) and cyanotic congenital heart disease (CHD) using data from five randomised controlled trials performed with identical protocols.

Methods

91 subjects (32 healthy, 22 with PVD with pulmonary arterial or distal chronic thromboembolic PH, 20 with COPD, 10 with PH in HFpEF and seven with CHD) performed two cycle

SUBMITTER: Muller J 

PROVIDER: S-EPMC10052458 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature